Literature DB >> 12681931

New antibiotics for anthrax?

Stephani Sutherland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12681931     DOI： 10.1016/s1359-6446(03)02665-5

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  3 in total

1.  YrxA is the transcriptional regulator that represses de novo NAD biosynthesis in Bacillus subtilis.

Authors:  Paola Rossolillo; Ilaria Marinoni; Elisa Galli; Anna Colosimo; Alessandra M Albertini
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

2.  SAR studies for a new class of antibacterial NAD biosynthesis inhibitors.

Authors:  Whitney Beysselance Moro; Zhengrong Yang; Tasha A Kane; Qingxian Zhou; Steve Harville; Christie G Brouillette; Wayne J Brouillette
Journal:  J Comb Chem       Date:  2009 Jul-Aug

3.  Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).

Authors:  Whitney Beysselance Moro; Zhengrong Yang; Tasha A Kane; Christie G Brouillette; Wayne J Brouillette
Journal:  Bioorg Med Chem Lett       Date:  2009-02-12       Impact factor: 2.823
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.